TerrAscend Corp. (TSNDF): Results of Operations and Financial Condition
TerrAscend Corp. (TSNDF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tsndf-ex99_1.htm EX-99.1 EX-99.1 TerrAscend Reports Second Quarter 2026 Financial Results Q2 2026 Net Revenue of $67.1 Million, Up Sequentially and Year-Over-Year Q2 2026 Gross Profit Margin of 54.0%, Up 120 Basis Points Sequentially and 290 Basis Points Year-Over-Year
How this was made
The 30-second read
Why it matters
Traders can update models for revenue, gross margin, cash generation, and leverage profile based on the convertible financing terms and the stated accretive dispensary acquisition agreement, plus monitor the Aug 24 shareholder vote tied to a potential U.S. exchange uplisting.
Market read
This is a company-specific earnings and financing update with concrete figures (revenue, margin, cash flow) and a balance-sheet extension to 2031, plus a near-term corporate milestone (Aug 24 share consolidation vote).
What to watch
The planned share consolidation vote (Aug 24) and Michigan assets being treated as discontinued operations could affect comparability and near-term investor perception more than the headline cash-flow yields.
Background
TerrAscend filed an SEC 8-K with Q2 2026 financial results (continuing operations) and additional corporate updates including officer changes and capital allocation actions.
Ticker impact
TerrAscend reported Q2 2026 results and disclosed an oversubscribed $21.8M convertible debt financing plus a New Jersey dispensary acquisition agreement.
Moderately positive bias for OTC liquidity and sentiment, with follow-through dependent on the shareholder vote for share consolidation and any subsequent uplisting progress.
Q2 shows sequential and YoY revenue and margin improvement, and the company extended convertible maturities to 2031 at a lower rate while adding an expected EBITDA and free-cash-flow accretive dispensary acquisition option.
Market effects
Cannabis operators may see read-through from improved margins and continued capital-market access via convertibles, though this is company-specific.
Strength cited across New Jersey, Maryland, and Pennsylvania retail and wholesale could reinforce competitive positioning in those states.
Limited, as the disclosure is primarily about TerrAscend’s North American operations and OTC/TSX listing mechanics.
Counterpoint
GAAP net loss persists and the acquisition is described as an option to acquire, so execution risk remains despite the stated accretion expectations.
Key entities
- companyTerrAscend Corp.
OTCQX: TSNDF, TSX: TSND cannabis operator reporting Q2 2026 results and financing and acquisition updates.
- executiveJason Wild
Executive Chairman quoted on Q2 performance, cash position, and balance-sheet strengthening.
- executiveEric Jackson
Appointed Chief Financial Officer during the quarter.
- executiveZiad Ghanem
Appointed to the Board of Directors as President and CEO.
- assetAunt Mary’s
High-performing New Jersey dispensary referenced in an agreement/option to acquire ownership.
